# Clinical Core

> **NIH NIH P30** · CLEVELAND CLINIC LERNER COM-CWRU · 2022 · $657,620

## Abstract

Project Summary
The theme of the Cleveland Alzheimer's Disease Center (CADRC) is focused on understanding the clinical and
pathologic heterogeneity observed in Alzheimer's disease (AD) and the AD-related dementias (ADRD), which
is in alignment with the broader goal of the National Alzheimer's Plan Act (NAPA). The Clinical Core (CC) and
Clinical Core Registry (CCR), a key resource of the CADRC, focus on several populations that can provide
special insights into this broad goal. The process of meeting this goal encompasses the major activities of the
CC, which include enrolling, characterizing, and following longitudinally a diverse population of older individuals
in the CCR (Specific Aims 1,2). Extensive interactions of the CC with other cores are essential for the function
of the CADRC and to meet this important goal. The diverse populations targeted for furthering this goal include
participants with Mild Cognitive Impairment/AD, dementia with Lewy bodies, Atypical AD dementias (Rapidly
progressive/Cortical Variant AD), and a cohort of cognitively normal controls with a large proportion having at
least one APOE e4 allele. A strong minority recruitment effort spanning multiple community- and clinic-based
approaches is outlined and builds upon the experience of the investigators working with this community, and
across cores, especially the Outreach, Recruitment, and Engagement Core (Specific Aim 6). The CC team
works with the Data Management and Statistics Core to store data to facilitate future research and to share
data with the National Alzheimer's Coordinating Center in a timely manner (Specific Aim 5).
The CC is the starting point for collection of biomarker, imaging and post-mortem autopsies to advance our
understanding of brain-behavior relationships by coordination with the Neuroimaging, Biomarker and
Neuropathology Cores. This involves the collection from CCR participants of blood and cerebral spinal fluid
biomarkers, 3T and 7T brain MRI and Amyloid PET imaging, and obtaining consent for post-mortem
neuropathology examination with brain autopsy across all of these diverse cohorts in a culturally sensitive and
efficient manner (Specific Aims 3,4).
The CC is committed to support future Administrative Core development projects and the Translational
Therapeutics Core and the Research Education Component in their mission to support basic scientist
investigators both locally, nationally, and internationally, and training the next generation of basic and clinical
science researchers (Specific Aims 7,8). Overall, the CC contributes to understanding AD in its fullest extent
across cultures and its varied clinical forms, while providing vital infrastructure for the basic, social, and clinical
researchers in our larger medical community.

## Key facts

- **NIH application ID:** 10474592
- **Project number:** 5P30AG072959-02
- **Recipient organization:** CLEVELAND CLINIC LERNER COM-CWRU
- **Principal Investigator:** Alan J Lerner
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $657,620
- **Award type:** 5
- **Project period:** 2021-09-01 → 2026-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10474592

## Citation

> US National Institutes of Health, RePORTER application 10474592, Clinical Core (5P30AG072959-02). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10474592. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*